Logiscreen

Resmed Inc

$218.27
Market Cap 31.66B
ROE 23.9%
Gross Margin 58.8%
Debt/Equity 0.1
Current Ratio 3.1
Revenue QoQ 8.6%
EPS QoQ 0.0%
F-Score 6

About

At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

Exchange
NYSE
Sector
Healthcare
Industry
Medical Instruments & Supplies

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
19.54
vs median 36.93
P/B
4.57
vs median 2.32
ROE
0.24
vs median 0.09

Decent quality with acceptable fundamentals

Large-cap company with established market presence

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics